107 related articles for article (PubMed ID: 731022)
1. e-Antigen: a link between immune response and infectivity in hepatitis B?
Turner GC; Green HT; Blundell VD
J Hyg (Lond); 1978 Dec; 81(3):405-14. PubMed ID: 731022
[TBL] [Abstract][Full Text] [Related]
2. Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage.
Alberti A; Diana S; Scullard GH; Eddleston WF; Williams R
Gastroenterology; 1978 Nov; 75(5):869-74. PubMed ID: 700329
[TBL] [Abstract][Full Text] [Related]
3. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
[TBL] [Abstract][Full Text] [Related]
4. Infectivity markers in HBsAg chronic carriers and intrafamilial spread of hepatitis B virus infection.
Pastore G; Dentico P; Angarano G; Lapedota E; Schiraldi O
Hepatogastroenterology; 1981 Feb; 28(1):20-2. PubMed ID: 7216135
[TBL] [Abstract][Full Text] [Related]
5. Correlations between the detection of e antigen or antibody and electron microscopic pattern of hepatitis B surface antigen (HBsAg) associated particles in the serum of HBsAg carriers.
Trepo C; Bird RG; Zuckerman AJ
J Clin Pathol; 1977 Mar; 30(3):216-20. PubMed ID: 403201
[TBL] [Abstract][Full Text] [Related]
6. HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.
Chadwick RG; Bassendine MF; Crawford EM; Thomas HC; Sherlock S
Br Med J; 1978 Aug; 2(6136):531-3. PubMed ID: 698557
[TBL] [Abstract][Full Text] [Related]
7. Relation of e antigen to infectivity of hBsAg-positive inoculations among medical personnel.
Lancet; 1976 Sep; 1(7984):492-4. PubMed ID: 74462
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans.
Tiku ML; Beutner KR; Tiku K; Ogra PL
J Infect Dis; 1978 Nov; 138(5):587-96. PubMed ID: 712116
[TBL] [Abstract][Full Text] [Related]
9. [The course of hepatitis B in 9 children who became positive for viral surface antigen HBsAg in spite of vaccination].
del Canho R; Grosheide PM; Heijtink RA; Schalm SW
Ned Tijdschr Geneeskd; 1993 Dec; 137(50):2599-603. PubMed ID: 8277987
[TBL] [Abstract][Full Text] [Related]
10. Dane particles and associated DNA-polymerase activity in saliva of chronic hepatitis B carriers.
Macaya G; Visoná KA; Villarejos VM
J Med Virol; 1979; 4(4):291-301. PubMed ID: 541682
[TBL] [Abstract][Full Text] [Related]
11. [Ways for the evaluation of the infectivity of HBS-Ag positive subjects].
Stalder GA
Schweiz Med Wochenschr; 1977 May; 107(18):614-7. PubMed ID: 867006
[TBL] [Abstract][Full Text] [Related]
12. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
[TBL] [Abstract][Full Text] [Related]
13. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
14. Immunoelectron microscopic observation of hepatitis B surface antigen on the surface of liver cells from patients with hepatitis B virus infection.
Yamada G; Takahashi T; Mizuno M; Sakamoto Y; Kaga K; Kobayashi T; Nagashima H
Acta Med Okayama; 1980 Jun; 34(3):175-87. PubMed ID: 6447986
[TBL] [Abstract][Full Text] [Related]
15. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
Zanetti AR
Boll Ist Sieroter Milan; 1977 Mar; 56(1):74-8. PubMed ID: 861075
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus (HBV) infections in turtles.
Lee WY; Yoo NC
Yonsei Med J; 1989; 30(2):144-50. PubMed ID: 2800564
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.
Perrillo RP; Gelb L; Campbell C; Wellinghoff W; Ellis FR; Overby L; Aach RD
Gastroenterology; 1979 Jun; 76(6):1319-25. PubMed ID: 437428
[TBL] [Abstract][Full Text] [Related]
18. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
[TBL] [Abstract][Full Text] [Related]
19. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation in European patients with the hepatitis B surface antigen.
Samuel D; Muller R; Alexander G; Fassati L; Ducot B; Benhamou JP; Bismuth H
N Engl J Med; 1993 Dec; 329(25):1842-7. PubMed ID: 8247035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
